Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial

BACKGROUND: Scalp hair loss (alopecia) in women is a common ageing and senescing condition. It usually presents as androgenetic alopecia (AGA) or telogen effluvium (TE) and often has pronounced psychological consequences. ALRV5XR is a novel treatment aiming to regenerate a normal hair phenotype by t...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldman, Peter R, Fiebig, Klaus M, Piwko, Charles, Mints, Boris M, Brown, Dennis, Cahan, Deborah J, Guevara-Aguirre, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249777/
https://www.ncbi.nlm.nih.gov/pubmed/34235415
http://dx.doi.org/10.1016/j.eclinm.2021.100978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249777/
https://www.ncbi.nlm.nih.gov/pubmed/34235415
http://dx.doi.org/10.1016/j.eclinm.2021.100978

Ejemplares similares